Supreme Court Verdict: Third-Party Drug Testers Not Liable for Negligence

In a landmark case that questioned the responsibilities of third-party drug testing entities when it comes to the termination of an employee, the Texas Supreme Court delivered a significant ruling. At the heart of the dispute was the issue of whether a third-party entity, hired by an employer to collect and test drug samples from employees, owed a common-law duty to perform these services with reasonable care. This article examines the details, legal arguments, and final outcome of this crucial case.

Background on the case and the role of third-party drug testing entities

The case involved an employee, referred to as the respondent, who worked as a pipefitter and had never tested positive for drug use during his employment. However, a particular drug test yielded a positive result for cocaine, which the respondent vehemently denied using. Consequently, the employee was required to complete a substance-abuse course by the Drug & Alcohol Testing Industry Association (DISA) before returning to work. Surprisingly, Turnaround, the respondent’s employer, refused to reassign him to any job site despite DISA’s approval.

Lawsuits and Claims against Third-Party Entities

Feeling wronged and unjustly terminated, the respondent filed a lawsuit against Turnaround. Eventually, he settled his claims with the employer and turned his attention towards Safety Council and Psychemedics, third-party entities responsible for collecting and processing his drug samples. According to the respondent, the alleged negligence of these entities led to his loss of employment. He sought legal redress for their alleged role in his termination.

Trial court and appellate court decisions

The trial court ruling came as a blow to the respondent when it determined that neither Safety Council nor Psychemedics owed him a legal duty. The court’s reasoning lay in the fact that these entities had no control over Turnaround’s decision to terminate the employee. However, on appeal, the Court of Appeals overturned the trial court’s decision. The appellate court found that a legal duty existed for third-party entities to use reasonable care in collecting and processing biological samples for drug testing.

Texas Supreme Court decision

The petitioners, Safety Council and Psychemedics, appealed the case to the Texas Supreme Court. In a definitive ruling, the Supreme Court sided with the petitioners, reversing the appellate court’s judgment. The court made it clear that third-party entities collecting or processing samples from employees did not owe a common-law duty of care. They highlighted that these entities had no control over the employer’s decision to terminate the employee, absolving them of any liability.

Arguments against imposing a new duty

The petitioners argued against imposing a new legal duty upon third-party drug testing entities, as it could lead to frivolous and burdensome claims. Additionally, they raised concerns about the potential transfer of responsibility, increased costs, and a decline in employment drug screens. They argued that imposing such a duty might prompt employers to take over the drug-testing programs themselves, potentially eroding the employment-at-will doctrine and exposing employers to further liability.

Implications and Consequences

Recognizing a new duty for third-party entities in collecting and processing samples from employees could have significant implications. Employers may choose to bring the drug testing program in-house to avoid potential liability, altering the current structure. This shift in responsibility might have consequences such as increased costs, delayed results, and potential conflicts of interest. Furthermore, it could undermine the employment-at-will doctrine, impacting employers’ flexibility in managing their workforce.

In a precedent-setting decision, the Texas Supreme Court ruled that third-party entities involved in collecting and processing employee drug samples do not owe a common-law duty to perform these services with reasonable care. The court’s reasoning emphasized the lack of control these entities had over the employer’s decision to terminate an employee. This ruling safeguards against potential frivolous claims, shields employers from unnecessary liability, and maintains the integrity of employment drug tests. However, it is essential to continue monitoring the evolving landscape around workplace drug testing and the role of third-party entities in ensuring a fair and responsible process.

Explore more

Will 6G Fail to Deliver on Its Multivendor Promise?

The global telecommunications landscape stands at a precarious crossroads where the lofty technical ambitions of 6G connectivity are colliding with the harsh commercial realities of a market that is increasingly consolidating. While early projections for the post-5G era promised a decentralized future where software and hardware from a dozen different suppliers would interoperate seamlessly, the actual roadmap suggests a return

Verizon Expands 6G Forum to Build AI-Native Networks

The invisible infrastructure that powers our digital lives is currently undergoing a radical metamorphosis, shifting from a passive transmission pipe into a sentient, self-aware organism capable of perceiving the physical environment with surgical precision. While the mobile industry spent the last decade focusing on the raw speed of handheld devices, the focus has shifted toward a future where the network

How Is AI-RAN Transforming Global Mobile Networks?

Telecommunications towers across the globe are quietly shedding their legacy skins to reveal an intelligence that was once confined to the high-security walls of experimental laboratories. This shift represents the most significant architectural change in a generation, as Artificial Intelligence Radio Access Network (AI-RAN) technology transitions from a conceptual blueprint into a functioning reality. Today, the static hardware that defined

Will AI in B2B Marketing Cut Costs or Fuel Performance?

The moment a marketing automation tool generates a month of hyper-personalized content in a fraction of a second, the fundamental value of human effort undergoes a radical shift. This is no longer a hypothetical scenario for the distant future; it is the baseline operational standard for B2B enterprises in 2026. Marketing leaders find themselves at a critical juncture where the

How Does Intelligence-Led Strategy Redefine B2B Influence?

The silent death of a multi-million dollar enterprise deal often occurs not because of a technical failure, but because the decision-makers simply stopped listening to the brand’s increasingly noisy corporate narrative. While organizations pour resources into high-fidelity video and glossed-over whitepapers, the average B2B buyer has developed a sophisticated filter for marketing rhetoric. This internal shield makes traditional distribution methods